Answers are grounded in this paper and cite their sources.
Objective: In our study, we aimed to investigate the relationship between the Interleukin-1β (IL-1β) +3953 gene polymorphism, the levels of this interleukin and smoking in osteointegrated dental implant losses. Materials and Methods: 56 patients with implants and 238 healthy control subjects were included in this study. PCR and RFLP methods was used to determine the IL-1β +3953 gene polymorphisms. Serum IL-1β levels were measured using ELISA. Results: The IL-1β +3953 CC, TT and CT genotype frequencies for the controls and study cases were 61.2%, 10.1% ,43.6%, and 48.2%, 8.9% and 42.9%, respectively. IL-1β +3953 T allele carriers increased more in the patient group (51.8%) compared to the control group (38.8%). These cases also had an increased plaque index, bleeding index, pocket deepness and serum IL-1β levels, but none of them were statistically significant (p>0.05). Implant losses were more frequent in C allele carriers than in T allele carriers, but this was not statistically significant (p>0.05) Three of the five patients that experienced implant loss and smoked, lost the implant earlier and had a higher average plaque and bleeding index. Conclusion: Based on our results, we can suggest that being an IL1β positive genotype and a smoker can have an effect on implant losses. The study group should be enlarged to comment with statistically significant results.
No takes yet. Share an insight, caveat, or question.
Dizen et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: